Sight Sciences to Report Fourth Quarter and Full Year 2024 Financial Results on March 5, 2025

Core Insights - Sight Sciences, Inc. will report its financial results for Q4 and the full year ended December 31, 2024, on March 5, 2025, after market close [1] - A conference call to discuss the results will take place at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on the same day [1] Company Overview - Sight Sciences is an eyecare technology company focused on developing innovative and interventional solutions to improve patient care and transform treatment paradigms [3] - The company offers the OMNI Surgical System, which is an implant-free glaucoma surgery technology aimed at reducing intraocular pressure in adult patients with primary open-angle glaucoma [3] - The SION Surgical Instrument is a bladeless device used in ophthalmic surgeries to excise trabecular meshwork [3] - The TearCare System is cleared in the U.S. for localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland dysfunction, addressing the leading cause of dry eye disease [3]